{"id":57497,"date":"2021-04-22T13:03:50","date_gmt":"2021-04-22T11:03:50","guid":{"rendered":"http:\/\/www.veeva.com\/eu\/?post_type=resources&#038;p=57497"},"modified":"2026-01-27T15:51:29","modified_gmt":"2026-01-27T14:51:29","slug":"veeva-unveils-quality-content-reference-model-to-empower-companies-with-proven-best-practices","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/veeva-unveils-quality-content-reference-model-to-empower-companies-with-proven-best-practices\/","title":{"rendered":"Veeva Unveils Quality Content Reference Model to Empower Companies with Proven Best Practices"},"content":{"rendered":"<p align=\"center\"><em>Industry best practices refined from over 300 customer implementations now publicly available<br \/>\nto companies modernizing their quality systems<\/em><\/p>\n<p><strong>BARCELONA, Spain \u2014 22 April 2021 <\/strong>\u2014 <a href=\"\/eu\/\">Veeva Systems<\/a> (NYSE: VEEV) today announced the availability of the Veeva Quality Content Reference Model to advance quality transformation efforts and drive further standardization in quality management. For the first time, documented best practices from hundreds of successful implementations of <a href=\"\/eu\/products\/veeva-qualitydocs\/\">Veeva QualityDocs<\/a> are now publicly available to accelerate system deployment and drive consistent and compliant GxP content practices across the enterprise.<\/p>\n<p>&#8220;The Veeva Quality Content Reference Model greatly simplifies stakeholder alignment and gap assessment for companies looking to modernize their quality solutions,&#8221; said Jan Paul Zonnenberg, partner, pharmaceutical and life sciences companies, PwC. &#8220;The content framework with industry best practices is a positive step for the industry and complements how we see process harmonization improving quality management.&#8221;<\/p>\n<p>Legacy and other document management systems require companies to invest months defining requirements and customizing configurations. This reference model, built right into Vault QualityDocs, streamlines the process by providing a standard document hierarchy, taxonomy, and metadata for organizing and delivering quality content. <\/p>\n<p>Emerging companies and established organizations alike can now align stakeholders and standardize content management across different business functions. The reference model also streamlines collaboration with contract partners that have become increasingly important to the overall product lifecycle. <\/p>\n<p>\u201cVeeva\u2019s quality customers are achieving significant efficiency gains by using our delivered best practices,\u201d said Mike Jovanis, vice president, Vault Quality at Veeva Systems. \u201cMaking the Veeva Quality Content Reference Model publicly available will enable further industry standardization and alignment across the life sciences value chain.\u201d   <\/p>\n<p>The Veeva Quality Content Reference Model is now available for companies readying to modernize their content management processes and system. <\/p>\n<p>Learn more about Vault Quality Suite at the upcoming <a href=\"\/eu\/events\/rd-summit\/overview\/\">Veeva R&#038;D and Quality Summit Connect Europe<\/a>, 20 May 2021. The online event is open to life sciences industry professionals. Register and stay up to date on program details at <a href=\"\/eu\/events\/rd-summit\/overview\/\">veeva.com\/Summit<\/a>.<\/p>\n<p><strong>Additional Information<\/strong><br \/>\nConnect with Veeva on LinkedIn: <a href=\"http:\/\/www.linkedin.com\/company\/veeva-systems\" target=\"_blank\" rel=\"noopener noreferrer\">linkedin.com\/company\/veeva-systems<\/a><br \/>\nFollow @veeva_eu on Twitter: <a href=\"https:\/\/twitter.com\/veeva_eu\" target=\"_blank\" rel=\"noopener noreferrer\">twitter.com\/veeva_eu<\/a><\/p>\n<p><strong>About Veeva Systems<\/strong><br \/>\nVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 975 customers, ranging from the world&#8217;s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit <a href=\"\/eu\/\">veeva.com\/eu<\/a>.<\/p>\n<p><strong>Forward-looking Statements<\/strong><br \/>\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended January 31, 2021. This is available on the company\u2019s website at <a href=\"\/\" target=\"_blank\" rel=\"noopener noreferrer\">veeva.com<\/a> under the Investors section and on the SEC\u2019s website at <a href=\"https:\/\/www.sec.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time. <\/p>\n<p class=\"text-center\">###<\/p>\n<p><strong>Contact:<\/strong><\/p>\n<p>Deivis Mercado<br \/>\nVeeva Systems<br \/>\n925-226-8821<br \/>\n<a href=\"mailto:deivis.mercado@veeva.com\">deivis.mercado@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Industry best practices refined from over 300 customer implementations now publicly available.<\/p>\n","protected":false},"featured_media":57522,"parent":0,"template":"","class_list":["post-57497","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-area-20-quality","resource-product-20-qualitydocs","resource-type-news-press-release","resource-type-press-release"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/57497"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":1,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/57497\/revisions"}],"predecessor-version":[{"id":57520,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/57497\/revisions\/57520"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/57522"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=57497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}